Guerriero, Eliana (2009) UbcH10 is useful in the diagnosis and prognosis of human neoplasms. [Tesi di dottorato] (Unpublished)


Download (5MB) | Preview
[error in script] [error in script]
Item Type: Tesi di dottorato
Resource language: English
Title: UbcH10 is useful in the diagnosis and prognosis of human neoplasms
Date: 2009
Number of Pages: 105
Institution: Università degli Studi di Napoli Federico II
Department: Biologia e patologia cellullare e molecolare "L. Califano"
Scuola di dottorato: Medicina molecolare
Dottorato: Oncologia ed endocrinologia molecolare
Ciclo di dottorato: 22
Coordinatore del Corso di dottorato:
Date: 2009
Number of Pages: 105
Settori scientifico-disciplinari del MIUR: Area 06 - Scienze mediche > MED/08 - Anatomia patologica
Date Deposited: 27 May 2010 14:58
Last Modified: 30 Apr 2014 19:39
DOI: 10.6092/UNINA/FEDOA/3944

Collection description

The UbcH10 gene belongs to the E2 gene family and encodes for a 19.6 kDa protein involved in ubiquitin-dependent proteolysis. The hybridization of an Affymetrix HG_U95Av2 microarray led us to highlight that this gene is up-regulated by 150 fold in all of the thyroid carcinoma cell lines in comparison to a primary cell culture of normal thyroid origin. To assess the role of UbcH10 in cancer progression, we analyzed its expression and its clinical/pathological relevance in breast and thyroid carcinomas and in lymphoproliferative diseases. In these tumor types, analysis of UbcH10 expression was performed on both cell lines and clinical samples by quantitative RT-PCR, Western blot, immunohistochemistry and flow cytometry. The effect of UbcH10 protein suppression by RNA interference was also evaluated in different tumor cell lines. Consistent data were derived from all tumor types. Deregulated UbcH10 expression was clearly associated to a highly malignant phenotype. Implications were both diagnostic and prognostic: UbcH10 specifically associated with the breast tumors more aggressive expressing ErbB2; UbcH10 specifically marked high grade non-Hodgkin lymphomas; high UbcH10 expression increased the suspicion of malignancy on preoperative thyroid biopsies. In several cell lines suppression of UbcH10 expression affected the neoplastic cell growth potential. All together our results indicate that UbcH10 is a marker of aggressive neoplastic behavior. Assessing its expression on clinical samples may contribute to both cancer diagnosis and prognosis. Moreover, the suppression of its function is to be evaluated as a potential therapeutic tool.


Downloads per month over past year

Actions (login required)

View Item View Item